Skip to main content
Top
Published in: BMC Women's Health 1/2019

Open Access 01-12-2019 | Magnetic Resonance Imaging | Research article

Development and internal validation of a Nomogram for preoperative prediction of surgical treatment effect on cesarean section diverticulum

Authors: Yizhi Wang, Qinyi Zhu, Feikai Lin, Li Xie, Jiarui Li, Xipeng Wang

Published in: BMC Women's Health | Issue 1/2019

Login to get access

Abstract

Background

The aim of this study was to develop and validate an individualized score based on preoperative parameters to predict patient outcomes after vaginal repair of cesarean section diverticulum.

Methods

This is a retrospective cohort study (Canadian Task Force classification II-2). Patients were enrolled between Jun 11, 2012, to May 27, 2016. Multivariable logistic regression analyses were used to construct the predictive model. Then, we generated a nomogram to assess the individualized risk of poor prognosis after operation. This prediction model included information from 167 eligible patients diagnosed with cesarean section diverticulum who underwent vaginal repair. Class-A healing group was defined as CSD patients who had menstruation duration of no more than 7 days and a thickness of the remaining muscular layer of no less than 5.8 mm after vaginal repair according to conferences. Others were included in the non-class-A healing group. A final nomogram was computed using a multivariable logistic regression model.

Results

The factors contained in the individualized prediction nomogram included the depth/ the thickness of the remaining muscular layer ratio, number of menstruation days before surgery, White blood cell and fibrinogen. This model demonstrated adequate discrimination and calibration (C-index = 0.718). There was a significant difference in the number of postmenstrual spotting days (12.98 ± 3.86 VS 14.46 ± 2.86, P = 0.022) and depth/ the thickness of the remaining muscular layer ratio (2.81 ± 1.54 VS 4.00 ± 3.09, P = 0.001) between two groups. Decision curve analysis showed that this nomogram was clinically useful.

Conclusions

This cesarean section diverticulum score can predict the outcomes of cesarean section diverticulum and can be useful for counseling patients who are making treatment decisions.
Literature
1.
go back to reference Luo L, Niu G, Wang Q, Xie HZ, Yao SZ. Vaginal repair of cesarean section scar diverticula. J Minim Invas Gyn. 2012;4:454–8.CrossRef Luo L, Niu G, Wang Q, Xie HZ, Yao SZ. Vaginal repair of cesarean section scar diverticula. J Minim Invas Gyn. 2012;4:454–8.CrossRef
3.
go back to reference Feng XL, Xu L, Guo Y, Ronsmans C. Factors influencing rising caesarean section rates in China between 1988 and 2008. B World Health Organ. 2012;90:30–6.CrossRef Feng XL, Xu L, Guo Y, Ronsmans C. Factors influencing rising caesarean section rates in China between 1988 and 2008. B World Health Organ. 2012;90:30–6.CrossRef
4.
go back to reference Hou L, Li G, Zou L, et al. Cesarean delivery rate and indications in mainland China: a cross sectional study in 2011. Chin J Obstet Gynecol. 2014;49(10):728–35. Hou L, Li G, Zou L, et al. Cesarean delivery rate and indications in mainland China: a cross sectional study in 2011. Chin J Obstet Gynecol. 2014;49(10):728–35.
5.
go back to reference Lf VDV, Am BDV, Veersema S, Huirne JA. Long-term complications of caesarean section. The niche in the scar: a prospective cohort study on niche prevalence and its relation to abnormal uterine bleeding. Bjog-Int J Obstet Gy. 2014;121:236–44.CrossRef Lf VDV, Am BDV, Veersema S, Huirne JA. Long-term complications of caesarean section. The niche in the scar: a prospective cohort study on niche prevalence and its relation to abnormal uterine bleeding. Bjog-Int J Obstet Gy. 2014;121:236–44.CrossRef
6.
go back to reference Bij de Vaate AJ, et al. Prevalence, potential risk factors for development and symptoms related to the presence of uterine niches following cesarean section: systematic review. Ultrasound Obstet Gynecol. 2014 Apr;43(4):372–82.CrossRef Bij de Vaate AJ, et al. Prevalence, potential risk factors for development and symptoms related to the presence of uterine niches following cesarean section: systematic review. Ultrasound Obstet Gynecol. 2014 Apr;43(4):372–82.CrossRef
7.
go back to reference Tower AM, Frishman GN. Cesarean scar defects: an underrecognized cause of abnormal uterine bleeding and other gynecologic complications. J Minim Invasive Gynecol. 2013 Sep-Oct;20(5):562–72.CrossRef Tower AM, Frishman GN. Cesarean scar defects: an underrecognized cause of abnormal uterine bleeding and other gynecologic complications. J Minim Invasive Gynecol. 2013 Sep-Oct;20(5):562–72.CrossRef
8.
go back to reference Raimondo G, Grifone G, Raimondo D, Seracchioli R, Scambia G, Masciullo V. Hysteroscopic treatment of symptomatic cesarean-induced Isthmocele: a prospective study. J Minim Invas Gyn. 2015;22:297–301.CrossRef Raimondo G, Grifone G, Raimondo D, Seracchioli R, Scambia G, Masciullo V. Hysteroscopic treatment of symptomatic cesarean-induced Isthmocele: a prospective study. J Minim Invas Gyn. 2015;22:297–301.CrossRef
9.
go back to reference Allornuvor GF, Xue M, Zhu X, Xu D. The definition, aetiology, presentation, diagnosis and management of previous caesarean scar defects. J Obstet Gynaecol. 2013;33:759–63.CrossRef Allornuvor GF, Xue M, Zhu X, Xu D. The definition, aetiology, presentation, diagnosis and management of previous caesarean scar defects. J Obstet Gynaecol. 2013;33:759–63.CrossRef
12.
go back to reference Tsuji S, Murakami T, Kimura F, Tanimura S, Kudo M, Shozu M, Narahara H, Sugino N. Management of secondary infertility following cesarean section: report from the Subcommittee of the Reproductive Endocrinology Committee of the Japan Society of Obstetrics and Gynecology. J Obstet Gynaecol Res 2015;41(9):1305–1312. https://doi.org/10.1111/jog.12750. Epub 2015 Jun 21.CrossRef Tsuji S, Murakami T, Kimura F, Tanimura S, Kudo M, Shozu M, Narahara H, Sugino N. Management of secondary infertility following cesarean section: report from the Subcommittee of the Reproductive Endocrinology Committee of the Japan Society of Obstetrics and Gynecology. J Obstet Gynaecol Res 2015;41(9):1305–1312. https://​doi.​org/​10.​1111/​jog.​12750. Epub 2015 Jun 21.CrossRef
13.
go back to reference Marotta ML, Donnez J, Squifflet J, Jadoul P, Darii N, Donnez O. Laparoscopic repair of post-cesarean section uterine scar defects diagnosed in nonpregnant women. J Minim Invas Gyn. 2013;20:386–91.CrossRef Marotta ML, Donnez J, Squifflet J, Jadoul P, Darii N, Donnez O. Laparoscopic repair of post-cesarean section uterine scar defects diagnosed in nonpregnant women. J Minim Invas Gyn. 2013;20:386–91.CrossRef
14.
go back to reference Donnez O, Jadoul P, Squifflet J, Donnez J. Laparoscopic repair of wide and deep uterine scar dehiscence after cesarean section. Fertil Steril. 2008;89:974–80.CrossRef Donnez O, Jadoul P, Squifflet J, Donnez J. Laparoscopic repair of wide and deep uterine scar dehiscence after cesarean section. Fertil Steril. 2008;89:974–80.CrossRef
15.
go back to reference Yao M, Chen H, Tao J, et al. Clinical research of transvaginal repair of cesarean scar diverticulum. Chin J Obstet Gynecol. 2015;50:500–5. Yao M, Chen H, Tao J, et al. Clinical research of transvaginal repair of cesarean scar diverticulum. Chin J Obstet Gynecol. 2015;50:500–5.
16.
go back to reference Fiocchi F, Petrella E, Nocetti L, et al. Transvaginal ultrasound assessment of uterine scar after previous caesarean section: comparison with 3T-magnetic resonance diffusion tensor imaging. Radiol Med. 2015;120:228–38.CrossRef Fiocchi F, Petrella E, Nocetti L, et al. Transvaginal ultrasound assessment of uterine scar after previous caesarean section: comparison with 3T-magnetic resonance diffusion tensor imaging. Radiol Med. 2015;120:228–38.CrossRef
17.
go back to reference Rodriguez-Wallberg K, Turan V, Munster P, Oktay K. Can ovarian suppression with gonadotropin-releasing hormone analogs (GnRHa) preserve fertility in cancer patients? Ann Oncol. 2016;27:357–62.CrossRef Rodriguez-Wallberg K, Turan V, Munster P, Oktay K. Can ovarian suppression with gonadotropin-releasing hormone analogs (GnRHa) preserve fertility in cancer patients? Ann Oncol. 2016;27:357–62.CrossRef
18.
go back to reference Lin YH, Hwang JL, Seow KM. Endometrial ablation as a treatment for postmenstrual bleeding due to cesarean scar defect. Power Electronics, Drives Systems and Technologies Conference. 2015;6:179–83. Lin YH, Hwang JL, Seow KM. Endometrial ablation as a treatment for postmenstrual bleeding due to cesarean scar defect. Power Electronics, Drives Systems and Technologies Conference. 2015;6:179–83.
19.
go back to reference Feng YL, Li MX, Liang XQ, Li XM. Hysteroscopic treatment of Postcesarean scar defect. J Minim Invas Gyn. 2012;19:498–502.CrossRef Feng YL, Li MX, Liang XQ, Li XM. Hysteroscopic treatment of Postcesarean scar defect. J Minim Invas Gyn. 2012;19:498–502.CrossRef
20.
go back to reference Li C, Guo Y, Liu Y, Cheng J, Zhang W. Hysteroscopic and laparoscopic management of uterine defects on previous cesarean delivery scars. J Perinat Med. 2014;42:363–70.CrossRef Li C, Guo Y, Liu Y, Cheng J, Zhang W. Hysteroscopic and laparoscopic management of uterine defects on previous cesarean delivery scars. J Perinat Med. 2014;42:363–70.CrossRef
21.
go back to reference Zhou J, Yao M, Wang H, Tan W, Chen P, Wang X. Vaginal repair of cesarean section scar diverticula that resulted in improved postoperative menstruation. J Minim Invas Gyn. 2016;23:969–78.CrossRef Zhou J, Yao M, Wang H, Tan W, Chen P, Wang X. Vaginal repair of cesarean section scar diverticula that resulted in improved postoperative menstruation. J Minim Invas Gyn. 2016;23:969–78.CrossRef
22.
go back to reference Tulandi T, Cohen A. Emerging manifestations of cesarean scar defect in reproductive-aged women. J Minim Invasive Gynecol. 2016 Sep-Oct;23(6):893–902.CrossRef Tulandi T, Cohen A. Emerging manifestations of cesarean scar defect in reproductive-aged women. J Minim Invasive Gynecol. 2016 Sep-Oct;23(6):893–902.CrossRef
24.
go back to reference Vikhareva Osser O, Valentin L. Clinical importance of appearance of cesarean hysterotomy scar at transvaginal ultrasonography in nonpregnant women. Obstet Gynecol. 2011 Mar;117(3):525–32.CrossRef Vikhareva Osser O, Valentin L. Clinical importance of appearance of cesarean hysterotomy scar at transvaginal ultrasonography in nonpregnant women. Obstet Gynecol. 2011 Mar;117(3):525–32.CrossRef
27.
go back to reference Zhou X, Yao M, Zhou J, Tan W, Wang H, Wang X. Defect width: the prognostic index for vaginal repair of cesarean section diverticula. Arch Gynecol Obstet. 2017;295:1–8.CrossRef Zhou X, Yao M, Zhou J, Tan W, Wang H, Wang X. Defect width: the prognostic index for vaginal repair of cesarean section diverticula. Arch Gynecol Obstet. 2017;295:1–8.CrossRef
28.
go back to reference Glavind J, Madsen LD, Uldbjerg N, Dueholm M. Ultrasound evaluation of cesarean scar after single- and double-layer uterotomy closure: a cohort study. Ultrasound Obst Gyn. 2013;42:207–12.CrossRef Glavind J, Madsen LD, Uldbjerg N, Dueholm M. Ultrasound evaluation of cesarean scar after single- and double-layer uterotomy closure: a cohort study. Ultrasound Obst Gyn. 2013;42:207–12.CrossRef
29.
go back to reference Sparano JA, Gray RJ, Makower DF, et al. Prospective validation of a 21-gene expression assay in breast Cancer. N Engl J Med. 2015;373:2005–14.CrossRef Sparano JA, Gray RJ, Makower DF, et al. Prospective validation of a 21-gene expression assay in breast Cancer. N Engl J Med. 2015;373:2005–14.CrossRef
30.
go back to reference Kramer AA, Zimmerman JE. Assessing the calibration of mortality benchmarks in critical care: the Hosmer-Lemeshow test revisited. Crit Care Med. 2007;35:2052–6.CrossRef Kramer AA, Zimmerman JE. Assessing the calibration of mortality benchmarks in critical care: the Hosmer-Lemeshow test revisited. Crit Care Med. 2007;35:2052–6.CrossRef
31.
go back to reference Balachandran VP, Gonen M, Smith JJ, RP DM. Nomograms in oncology: more than meets the eye. Lancet Oncol. 2015;16:173–80.CrossRef Balachandran VP, Gonen M, Smith JJ, RP DM. Nomograms in oncology: more than meets the eye. Lancet Oncol. 2015;16:173–80.CrossRef
32.
go back to reference Collins GS, Reitsma JB, Altman DG, Moons KGM. Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD statement. Diabetic Med. 2015;15:146–54.CrossRef Collins GS, Reitsma JB, Altman DG, Moons KGM. Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD statement. Diabetic Med. 2015;15:146–54.CrossRef
33.
go back to reference Oktay K, Bedoschi G. Appraising the biological evidence for and against the utility of GnRHa for preservation of fertility in patients with Cancer. J Clin Oncol. 2016;34:2563–5.CrossRef Oktay K, Bedoschi G. Appraising the biological evidence for and against the utility of GnRHa for preservation of fertility in patients with Cancer. J Clin Oncol. 2016;34:2563–5.CrossRef
Metadata
Title
Development and internal validation of a Nomogram for preoperative prediction of surgical treatment effect on cesarean section diverticulum
Authors
Yizhi Wang
Qinyi Zhu
Feikai Lin
Li Xie
Jiarui Li
Xipeng Wang
Publication date
01-12-2019
Publisher
BioMed Central
Published in
BMC Women's Health / Issue 1/2019
Electronic ISSN: 1472-6874
DOI
https://doi.org/10.1186/s12905-019-0817-z

Other articles of this Issue 1/2019

BMC Women's Health 1/2019 Go to the issue